Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial updating safety and efficacy evaluation of CJ-30061 in patients with hypertension and hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• CJ-30061

Snippet

Sponsor: HK inno.N Corporation | Conditions: Hypertension, Hyperlipidemia | Phase 3 | Status: UNKNOWN